Primary Hyperparathyroidism Complicated by Osteomalacia

Karstrup S Holm HH Thorp-Pederson S Hegedus L. Ultrasonically guided percutaneous inactivation of parathyroid tumours. Br J Radiol 1987; 60: 667–70.

Karstrup S Transbol I Holm HH Glenthoj A Hegedus L. Ultrasound-guided chemical parathyroidectomy in patient with primary hyperparathyroidism: A prospective study. Br J Radiol 1989; 62: 1037–42.

Woodhouse NJY Doyle FG Joplin GF . Vitamin D deficiency and primary hyperparathyroidism. Lancet 1971; ii: 283–7.

Clements MR Davies M Fraser DR Lumb GA Mawer EB Adams PH . Metabolic inactivation of vitamin D is enhanced by primary hyperparathyroidism. Clin Sci 1987; 73: 659–54.

Boyce D Jowsey J. Measurement of osteoid tissue in primary hyperparathyroidism. Mayo Clin Proc 1966; 41: 836.

Takemia T Sato K Miyata M Imaki T Shibasaki T Tsushima T A patient with primary hyperparathyroidism associated with osteomalacia: Markedly increased serum levels of intact PTH and 1,25-dihydroxyvitamin D with normo- and hypercalcaemia. Endocr J 1993; 40: 121–6.

Weinstein RS Harris RL . Hypercalcemic hyperparathyroidism and hypophosphatemic osteomalacia complicating neurofibromatosis. Calcif Tissue Int 1990; 46: 361–6.

Meng X. Primary hyperparathyroidism complicated by osteomalacia. Chung Hua I Hsueh Tsa Chih 1990; 70: 636–8.

Solbiati L Giangrande A De Pra L Bellotti E Cantu P Ravetto C. Percutaneous ethanol injection of parathyroid tumours under US guidance; treatment of secondary hyperparathyroidism. Radiology 1985; 155: 607–10.

Heath DA Van't Hoff W Barnes AD Gray JG . Value of 1 α-hydroxyvitamin D3 in treatment of primary hyperparathyroidism before parathyroidectomy. BMJ 1979; i: 450–2.